15.16
price up icon1.34%   0.20
after-market アフターアワーズ: 15.14 -0.02 -0.13%
loading
前日終値:
$14.96
開ける:
$15.0086
24時間の取引高:
3,522
Relative Volume:
0.88
時価総額:
$N/A
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.86%
1か月 パフォーマンス:
+1.40%
6か月 パフォーマンス:
-4.41%
1年 パフォーマンス:
+41.55%
1日の値動き範囲:
Value
$15.01
$15.16
1週間の範囲:
Value
$14.58
$15.16
52週間の値動き範囲:
Value
$9.5201
$17.96

Range Cancer Therapeutics Etf Stock (CNCR) Company Profile

Name
名前
Range Cancer Therapeutics Etf
Name
セクター
Financial (4779)
Name
電話
-
Name
住所
-
Name
職員
0
Name
Twitter
@LoncarFunds
Name
次回の収益日
Name
最新のSEC提出書
Name
CNCR's Discussions on Twitter

Range Cancer Therapeutics Etf (CNCR) 最新ニュース

pulisher
Oct 31, 2024

(CNCR) Trading Report - Stock Traders Daily

Oct 31, 2024
pulisher
Oct 29, 2024

The 5 Best Biotech ETFs of 2024 - TradingView

Oct 29, 2024
pulisher
Oct 20, 2024

(CNCR) Investment Report - Stock Traders Daily

Oct 20, 2024
pulisher
Oct 14, 2024

5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network

Oct 14, 2024
pulisher
Oct 14, 2024

4 Cancer Stocks to Consider in 2024 - The Motley Fool

Oct 14, 2024
pulisher
Oct 11, 2024

The Zacks Analyst Blog SFYX, CNCR, FXN and DIV - Yahoo Finance

Oct 11, 2024
pulisher
Oct 10, 2024

4 Solid ETFs Under $20 for Your Portfolio - Yahoo Finance

Oct 10, 2024
pulisher
Oct 09, 2024

(CNCR) Investment Analysis - Stock Traders Daily

Oct 09, 2024
pulisher
Oct 04, 2024

Summit Therapeutics: Cancer Drug With Great Potential On 'Fast Track' To US Market (SMMT) - Seeking Alpha

Oct 04, 2024
pulisher
Oct 03, 2024

7 Best-Performing Biotech ETFs for November 2024 - NerdWallet

Oct 03, 2024
pulisher
Oct 01, 2024

Trackinsight ETF data from 23rd to 27th September, 2024 - ETF Express

Oct 01, 2024
pulisher
Sep 29, 2024

(CNCR) Investment Analysis and Advice - Stock Traders Daily

Sep 29, 2024
pulisher
Sep 18, 2024

When the Price of (CNCR) Talks, People Listen - Stock Traders Daily

Sep 18, 2024
pulisher
Sep 18, 2024

Breaking Down Acrivon: Deep Dive Into Revenue, Profitability, And Prospects (NASDAQ:ACRV) - Seeking Alpha

Sep 18, 2024
pulisher
Sep 17, 2024

7 Top Gene-Editing Stocks to Buy | Investing - U.S News & World Report Money

Sep 17, 2024
pulisher
Sep 16, 2024

Roundhill Investments Surpasses $2 Billion AUM Milestone – Company Announcement - Financial Times

Sep 16, 2024
pulisher
Sep 10, 2024

5 ETFs That Led the Rebound on Monday - Yahoo Finance

Sep 10, 2024
pulisher
Sep 09, 2024

IPO Roundup: Bicara Therapeutics, Kairos Pharma and more (NYSEARCA:IPO) - Seeking Alpha

Sep 09, 2024
pulisher
Sep 02, 2024

Trading (CNCR) With Integrated Risk Controls - Stock Traders Daily

Sep 02, 2024
pulisher
Aug 30, 2024

Cellectis: Cheap With Promising But Speculative Cancer Therapies (NASDAQ:CLLS) - Seeking Alpha

Aug 30, 2024
pulisher
Aug 28, 2024

Best-Performing ETF Areas of Past Week - MSN

Aug 28, 2024
pulisher
Aug 26, 2024

TScan Therapeutics: Speculative Buy With Near-Term Catalysts In Oncology (TCRX) - Seeking Alpha

Aug 26, 2024
pulisher
Aug 13, 2024

Why It May Be 'Just Right' to Invest in Cancer Therapeutics Development Stocks Now - Nasdaq

Aug 13, 2024
pulisher
Aug 12, 2024

3 Top-Ranked ETFs Under $20 for Your Portfolio - MSN

Aug 12, 2024
pulisher
Aug 10, 2024

(CNCR) Long Term Investment Analysis - Stock Traders Daily

Aug 10, 2024
pulisher
Aug 07, 2024

Invest in Hope, Invest in Life - Nasdaq

Aug 07, 2024
pulisher
Aug 07, 2024

5 Top-Ranked ETFs to Buy at a Bargain - Yahoo Finance

Aug 07, 2024
pulisher
Aug 06, 2024

Wall Street indexes rise after strong jobs data - Yahoo News Canada

Aug 06, 2024
pulisher
Jul 29, 2024

VIXY Jumped 7.3% Last Week - Yahoo Finance

Jul 29, 2024
pulisher
Jul 29, 2024

SPY Led Inflows Last Week as Leveraged Funds Surged - etf.com

Jul 29, 2024
pulisher
Jul 29, 2024

Best ETFs of Last Week - Yahoo Finance

Jul 29, 2024
pulisher
Jul 28, 2024

US stocks waver, extending tech-led selloff - Yahoo Singapore News

Jul 28, 2024
pulisher
Jul 23, 2024

Time for Healthcare ETFs? - Yahoo Finance

Jul 23, 2024
pulisher
Jul 17, 2024

TSLA-related ETFs among top performing ETFs on a 4-week performance base last week - MSN

Jul 17, 2024
pulisher
Jul 15, 2024

5 Top ETFs of Last Week - Yahoo Finance

Jul 15, 2024
pulisher
Jul 11, 2024

US consumer inflation eases more than expected - Yahoo Singapore News

Jul 11, 2024
pulisher
Jul 10, 2024

How the (CNCR) price action is used to our Advantage - Stock Traders Daily

Jul 10, 2024
pulisher
Jul 08, 2024

GordonMD® Global Investments Portfolio Company, Radionetics Oncology, Announced Strategic Agreement with Lilly - Yahoo Finance

Jul 08, 2024
pulisher
Jul 02, 2024

All you need to know about: Malaysia’s new cost-of-living benchmark - Yahoo News Malaysia

Jul 02, 2024
pulisher
Jul 02, 2024

HHLHarvest ETFs: Harvest Healthcare Leaders Income ETF - The Globe and Mail

Jul 02, 2024
pulisher
Jul 02, 2024

Tesla: Should You Buy the Stock Before Firm’s Q2 Deliveries Report? - Investing.com

Jul 02, 2024
pulisher
Jul 02, 2024

4 Up-and-Coming Small-Cap Biotech Stocks to Watch - Investing.com

Jul 02, 2024
pulisher
Jun 30, 2024

S&P 500, Nasdaq close higher to kick off second half's trading: Live updates - CNBC

Jun 30, 2024
pulisher
Jun 30, 2024

(CNCR) Proactive Strategies - Stock Traders Daily

Jun 30, 2024
pulisher
Jun 30, 2024

Reviewing Replimune Group (NASDAQ:REPL) and Cyclo Therapeutics (NASDAQ:CYTH) - Defense World

Jun 30, 2024
pulisher
Jun 28, 2024

7 Best Biotech ETFs to Buy Now | Investing - U.S News & World Report Money

Jun 28, 2024
pulisher
Jun 27, 2024

Black Diamond: High-Risk, High-Reward, Low-Profile EGFR Inhibitor Worth A Deep Dive (BDTX) - Seeking Alpha

Jun 27, 2024
pulisher
Jun 26, 2024

How to Invest in the Semiconductor Value Chain with These ETFs - The Globe and Mail

Jun 26, 2024
pulisher
Jun 25, 2024

BMO ETFs: Balancing Growth and Income - The Globe and Mail

Jun 25, 2024
pulisher
Jun 25, 2024

Oncology Stocks: 8 Biggest NASDAQ Companies in 2024 | INN - Investing News Network

Jun 25, 2024
pulisher
Jun 20, 2024

Where are the Opportunities in (CNCR) - Stock Traders Daily

Jun 20, 2024

Range Cancer Therapeutics Etf (CNCR) 財務データ

Range Cancer Therapeutics Etf (CNCR) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
exchange_traded_fund VTV
$173.57
price up icon 1.06%
exchange_traded_fund VUG
$390.21
price up icon 1.38%
exchange_traded_fund IJH
$63.10
price up icon 1.45%
exchange_traded_fund EFA
$80.23
price up icon 0.99%
exchange_traded_fund IWF
$380.80
price up icon 1.39%
exchange_traded_fund QQQ
$492.21
price up icon 1.28%
大文字化:     |  ボリューム (24 時間):